Julia Vipond

612 total citations
16 papers, 415 citations indexed

About

Julia Vipond is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Julia Vipond has authored 16 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Julia Vipond's work include Tuberculosis Research and Epidemiology (6 papers), Bacillus and Francisella bacterial research (4 papers) and Viral Infections and Vectors (3 papers). Julia Vipond is often cited by papers focused on Tuberculosis Research and Epidemiology (6 papers), Bacillus and Francisella bacterial research (4 papers) and Viral Infections and Vectors (3 papers). Julia Vipond collaborates with scholars based in United Kingdom, New Zealand and United States. Julia Vipond's co-authors include Nigel P. Minton, Vladimír Berka, C.S. Raman, Ah‐Lim Tsai, Graham Hatch, Julia A. Tree, Kevin R. Bewley, Simon G. P. Funnell, Ann Williams and Allen D. G. Roberts and has published in prestigious journals such as Science, Journal of Virology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Julia Vipond

16 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Vipond United Kingdom 10 228 147 125 93 88 16 415
Beatriz Apellániz Spain 15 408 1.8× 61 0.4× 245 2.0× 89 1.0× 20 0.2× 28 582
Serena Cervantes United States 8 137 0.6× 117 0.8× 39 0.3× 42 0.5× 51 0.6× 10 364
Tracey L. Schultz United States 13 247 1.1× 306 2.1× 61 0.5× 54 0.6× 23 0.3× 18 699
Jun Iwahashi Japan 13 331 1.5× 127 0.9× 14 0.1× 49 0.5× 94 1.1× 27 516
Franziska Arnold Germany 4 119 0.5× 34 0.2× 98 0.8× 60 0.6× 23 0.3× 5 249
Karsten Bruns Germany 13 381 1.7× 228 1.6× 196 1.6× 117 1.3× 13 0.1× 17 641
Emmanuel Adu‐Gyamfi United States 12 189 0.8× 175 1.2× 20 0.2× 265 2.8× 80 0.9× 14 489
Dylan Harris United States 14 393 1.7× 77 0.5× 250 2.0× 227 2.4× 11 0.1× 15 594
Christine Cruz-Oliveira Brazil 8 104 0.5× 73 0.5× 35 0.3× 266 2.9× 22 0.3× 10 554
Vaibhav B. Shah United States 13 294 1.3× 133 0.9× 533 4.3× 398 4.3× 17 0.2× 15 791

Countries citing papers authored by Julia Vipond

Since Specialization
Citations

This map shows the geographic impact of Julia Vipond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Vipond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Vipond more than expected).

Fields of papers citing papers by Julia Vipond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Vipond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Vipond. The network helps show where Julia Vipond may publish in the future.

Co-authorship network of co-authors of Julia Vipond

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Vipond. A scholar is included among the top collaborators of Julia Vipond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Vipond. Julia Vipond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hartley, M. Gill, Isobel H. Norville, Kevin R. Bewley, et al.. (2021). Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever. Frontiers in Microbiology. 12. 760698–760698. 5 indexed citations
2.
Hartley, M. Gill, Stuart J. Armstrong, Kevin R. Bewley, et al.. (2021). Evaluation of the Efficacy of Doxycycline, Ciprofloxacin, Levofloxacin, and Co-trimoxazole Using In Vitro and In Vivo Models of Q Fever. Antimicrobial Agents and Chemotherapy. 65(11). e0067321–e0067321. 5 indexed citations
3.
Funnell, Simon G. P., Julia A. Tree, Graham Hatch, et al.. (2019). Dose‐dependant acute or subacute disease caused byBurkholderia pseudomalleistrain NCTC 13392 in a BALB/c aerosol model of infection. Journal of Applied Microbiology. 127(4). 1224–1235. 3 indexed citations
4.
Tree, Julia A., et al.. (2016). Repeated high-dose (5 × 108TCID50) toxicity study, of a third generation smallpox vaccine (IMVAMUNE), in New Zealand white rabbits. Human Vaccines & Immunotherapeutics. 12(7). 0–0. 5 indexed citations
5.
Tree, Julia A., G.A. Hall, G. R. Pearson, et al.. (2015). Sequence of Pathogenic Events in Cynomolgus Macaques Infected with Aerosolized Monkeypox Virus. Journal of Virology. 89(8). 4335–4344. 27 indexed citations
6.
Negus, David, Julia Vipond, Graham Hatch, Emma Rayner, & Peter W. Taylor. (2015). Parenteral Administration of Capsule Depolymerase EnvD Prevents Lethal Inhalation Anthrax Infection. Antimicrobial Agents and Chemotherapy. 59(12). 7687–7692. 7 indexed citations
7.
Norville, Isobel H., Graham Hatch, Kevin R. Bewley, et al.. (2014). Efficacy of Liposome-Encapsulated Ciprofloxacin in a Murine Model of Q Fever. Antimicrobial Agents and Chemotherapy. 58(9). 5510–5518. 21 indexed citations
8.
Hatch, Graham, Victoria Graham, Kevin R. Bewley, et al.. (2013). Assessment of the Protective Effect of Imvamune and Acam2000 Vaccines against Aerosolized Monkeypox Virus in Cynomolgus Macaques. Journal of Virology. 87(14). 7805–7815. 103 indexed citations
9.
Vipond, Julia, et al.. (2013). Sequence Determination of Burkholderia pseudomallei Strain NCTC 13392 Colony Morphology Variants. Genome Announcements. 1(6). 9 indexed citations
10.
11.
Vipond, Julia, Martin L. Cross, Matthew R. Lambeth, et al.. (2008). Immunogenicity of orally-delivered lipid-formulated BCG vaccines and protection against Mycobacterium tuberculosis infection. Microbes and Infection. 10(14-15). 1577–1581. 10 indexed citations
12.
13.
Clark, Simon, Martin L. Cross, Julia Vipond, et al.. (2008). Oral Vaccination of Guinea Pigs with aMycobacterium bovisBacillus Calmette-Guerin Vaccine in a Lipid Matrix Protects against Aerosol Infection with VirulentM. bovis. Infection and Immunity. 76(8). 3771–3776. 20 indexed citations
14.
Vipond, Julia, Richard Vipond, Emma Allen‐Vercoe, et al.. (2006). Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge. Vaccine. 24(37-39). 6340–6350. 23 indexed citations
15.
Vipond, Julia, Simon Clark, Graham Hatch, et al.. (2006). Re-formulation of selected DNA vaccine candidates and their evaluation as protein vaccines using a guinea pig aerosol infection model of tuberculosis. Tuberculosis. 86(3-4). 218–224. 10 indexed citations
16.
Berka, Vladimír, et al.. (2004). Femtomolar Sensitivity of a NO Sensor from Clostridium botulinum. Science. 306(5701). 1550–1553. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beatriz Apellániz Breakdown of academic impact, for papers by Serena Cervantes Breakdown of academic impact, for papers by Tracey L. Schultz Breakdown of academic impact, for papers by Jun Iwahashi Breakdown of academic impact, for papers by Franziska Arnold Breakdown of academic impact, for papers by Karsten Bruns Breakdown of academic impact, for papers by Emmanuel Adu‐Gyamfi Breakdown of academic impact, for papers by Dylan Harris Breakdown of academic impact, for papers by Christine Cruz-Oliveira Breakdown of academic impact, for papers by Vaibhav B. Shah
Rankless by CCL
2026